June 2026 Boston Scientific continued strengthening its gastrointestinal endoscopy portfolio, including advanced endoscopic closure and suturing technologies used for minimally invasive gastrointestinal procedures. The company maintained focus on expanding therapeutic endoscopy solutions for defect closure, bariatric interventions, and complex GI procedures.
May 2026 Endoluminal suturing device manufacturers continued advancing next-generation endoscopic suturing platforms designed for gastrointestinal defect closure, endoscopic sleeve gastroplasty, fistula repair, leak closure, and stent fixation procedures. Market developments reflected increasing adoption of minimally invasive approaches across hospitals and ambulatory surgical centers.
March 2026 MedTech companies expanded investments in therapeutic endoscopy technologies, including flexible endoscopic systems and accessories that enable full-thickness suturing through natural orifice procedures. These innovations supported the shift toward incisionless and reduced-recovery surgical techniques.
January 2026 Healthcare providers continued increasing adoption of endoluminal suturing systems for bariatric procedures, gastrointestinal defect management, and post-surgical complication repair. Demand increased for devices offering improved precision, ease of deployment, and compatibility with advanced endoscopic platforms.